Summary
M2 EQUITYBITES-May 9, 2011-Abbott announces FDA approval receipt for expanded use of the RX ACCULINK Carotid Stent System
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Acculink Carotid Stent System
Broad based health care company Abbott (NYSE:ABT) on Friday announced that the US...
See the full content of this document
Sponsored links
